Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 228.49 USD -0.54% Market Closed
Market Cap: 403.8B USD

Wall Street
Price Targets

ABBV Price Targets Summary
Abbvie Inc

Wall Street analysts forecast ABBV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABBV is 249.74 USD with a low forecast of 189.52 USD and a high forecast of 303.45 USD.

Lowest
Price Target
189.52 USD
17% Downside
Average
Price Target
249.74 USD
9% Upside
Highest
Price Target
303.45 USD
33% Upside
Abbvie Inc Competitors:
Price Targets
PRME
Prime Medicine Inc
90% Upside
ZNTL
Zentalis Pharmaceuticals Inc
301% Upside
CNTB
Connect Biopharma Holdings Ltd
186% Upside
ALNY
Alnylam Pharmaceuticals Inc
25% Upside
300896
Imeik Technology Development Co Ltd
41% Upside
RYTM
Rhythm Pharmaceuticals Inc
29% Upside
688192
Dizal Jiangsu Pharmaceutical Co Ltd
68% Upside
PEB
Pacific Edge Ltd
31% Downside

Revenue
Forecast

Revenue Estimate
Abbvie Inc

For the last 13 years the compound annual growth rate for Abbvie Inc's revenue is 9%. The projected CAGR for the next 4 years is 9%.

9%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Abbvie Inc

For the last 13 years the compound annual growth rate for Abbvie Inc's operating income is 11%. The projected CAGR for the next 4 years is 25%.

11%
Past Growth
25%
Estimated Growth
Estimates Accuracy
-18%
Average Miss

Net Income
Forecast

Net Income Estimate
Abbvie Inc

For the last 13 years the compound annual growth rate for Abbvie Inc's net income is 2%. The projected CAGR for the next 4 years is 65%.

2%
Past Growth
65%
Estimated Growth
Estimates Accuracy
-51%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ABBV's stock price target?
Price Target
249.74 USD

According to Wall Street analysts, the average 1-year price target for ABBV is 249.74 USD with a low forecast of 189.52 USD and a high forecast of 303.45 USD.

What is Abbvie Inc's Revenue forecast?
Projected CAGR
9%

For the last 13 years the compound annual growth rate for Abbvie Inc's revenue is 9%. The projected CAGR for the next 4 years is 9%.

What is Abbvie Inc's Operating Income forecast?
Projected CAGR
25%

For the last 13 years the compound annual growth rate for Abbvie Inc's operating income is 11%. The projected CAGR for the next 4 years is 25%.

What is Abbvie Inc's Net Income forecast?
Projected CAGR
65%

For the last 13 years the compound annual growth rate for Abbvie Inc's net income is 2%. The projected CAGR for the next 4 years is 65%.

Back to Top